| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 6 699-710, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
EK Han, M Begemann, A Sgambato, JW Soh, Y Doki, WQ Xing, W Liu and IB Weinstein
Columbia-Presbyterian Cancer Center, Columbia Univerisity, College of Physicians and Surgeons, New York, New York 10032, USA.
Cyclin D1 is frequently amplified and/or overexpressed in human breast cancer and several other types of cancer. To examine the role of cyclin D1 in normal mammary epithelial cells, in the present study we have overexpressed human cyclin D1 in the mouse mammary epithelial cell line HC11, using retrovirus-mediated transduction. We found that the cyclin D1 overexpresser clones displayed a decrease in saturation density, a decrease in anchorage-independent growth, an increased fraction of cells in the G(zero)-G1 phase, and increased expression of beta-casein, when compared to the control cells. The latter finding suggested that they were more differentiated. Furthermore, the cyclin D1 overexpressers displayed a marked increase in susceptibility to induction of apoptosis by serum withdrawal or by treatment with hydroxyurea or the protein kinase C inhibitors CGP 41251 and Ro31-8220. Thus, in some mammary epithelial cells, increased expression of cyclin D1 can inhibit growth, induce differentiation, and enhance apoptosis. These effects might be due, at least in part, to the fact that these derivatives displayed increased expression of the p27kip1 inhibitory protein.
This article has been cited by other articles:
 |
|
 |
|
  A. Thakur, Y. Sun, A. Bollig, J. Wu, H. Biliran, S. Banerjee, F. H. Sarkar, and D. J. Liao Anti-invasive and Antimetastatic Activities of Ribosomal Protein S6 Kinase 4 in Breast Cancer Cells Clin. Cancer Res., July 15, 2008; 14(14): 4427 - 4436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lee, W. C. Park, H. W. Yim, M. A. Lee, G. Park, and K. Y. Lee Expression of c-erbB2, cyclin D1 and Estrogen Receptor and their Clinical Implications in the Invasive Ductal Carcinoma of the Breast Jpn. J. Clin. Oncol., September 1, 2007; 37(9): 708 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Castro, J. D. Amaral, S. Sola, B. T. Kren, C. J. Steer, and C. M. P. Rodrigues Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G327 - G334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, A. Thakur, Y. Sun, J. Wu, H. Biliran, A. Bollig, and D. J. Liao Synergistic Effect of Cyclin D1 and c-Myc Leads to More Aggressive and Invasive Mammary Tumors in Severe Combined Immunodeficient Mice Cancer Res., April 15, 2007; 67(8): 3698 - 3707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Yogev, S. Anzi, K. Inoue, and E. Shaulian Induction of Transcriptionally Active Jun Proteins Regulates Drug-induced Senescence J. Biol. Chem., November 10, 2006; 281(45): 34475 - 34483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Fasanaro, A. Magenta, G. Zaccagnini, L. Cicchillitti, S. Fucile, F. Eusebi, P. Biglioli, M. C. Capogrossi, and F. Martelli Cyclin D1 degradation enhances endothelial cell survival upon oxidative stress FASEB J, June 1, 2006; 20(8): 1242 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wallace and K. L. Ball Docking-Dependent Regulation of the Rb Tumor Suppressor Protein by Cdk4 Mol. Cell. Biol., June 15, 2004; 24(12): 5606 - 5619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.A. C. Pratt and M.-Y. Niu Bcl-2 Controls Caspase Activation Following a p53-dependent Cyclin D1-induced Death Signal J. Biol. Chem., April 11, 2003; 278(16): 14219 - 14229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Berardi, M. Meyyappan, and K. T. Riabowol A Novel Transcriptional Inhibitory Element Differentially Regulates the Cyclin D1 Gene in Senescent Cells J. Biol. Chem., February 21, 2003; 278(9): 7510 - 7519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Crowley, E. M. Kaine, M. Yoshida, A. Nandi, and D. J. Wolgemuth Reproductive Cycle Regulation of Nuclear Import, Euchromatic Localization, and Association with Components of Pol II Mediator of a Mammalian Double-Bromodomain Protein Mol. Endocrinol., August 1, 2002; 16(8): 1727 - 1737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mazumder, B. Gong, Q. Chen, J. A. Drazba, J. C. Buchsbaum, and A. Almasan Proteolytic Cleavage of Cyclin E Leads to Inactivation of Associated Kinase Activity and Amplification of Apoptosis in Hematopoietic Cells Mol. Cell. Biol., April 1, 2002; 22(7): 2398 - 2409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Wolter, A. Clausnitzer, B. Akoglu, and J. Stein Piceatannol, a Natural Analog of Resveratrol, Inhibits Progression through the S Phase of the Cell Cycle in Colorectal Cancer Cell Lines J. Nutr., February 1, 2002; 132(2): 298 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. You, W. Yu, B. G. Sanders, and K. Kline RRR-{alpha}-Tocopheryl Succinate Induces MDA-MB-435 and MCF-7 Human Breast Cancer Cells to Undergo Differentiation Cell Growth Differ., September 1, 2001; 12(9): 471 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wolter, B. Akoglu, A. Clausnitzer, and J. Stein Downregulation of the Cyclin D1/Cdk4 Complex Occurs during Resveratrol-Induced Cell Cycle Arrest in Colon Cancer Cell Lines J. Nutr., August 1, 2001; 131(8): 2197 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lamb, M. H. Ladha, C. McMahon, R. L. Sutherland, and M. E. Ewen Regulation of the Functional Interaction between Cyclin D1 and the Estrogen Receptor Mol. Cell. Biol., December 1, 2000; 20(23): 8667 - 8675. [Abstract] [Full Text]
|
|
|
|
|
|
A. P. Albino, G. Juan, F. Traganos, L. Reinhart, J. Connolly, D. P. Rose, and Z. Darzynkiewicz Cell Cycle Arrest and Apoptosis of Melanoma Cells by Docosahexaenoic Acid: Association with Decreased pRb Phosphorylation Cancer Res., August 1, 2000; 60(15): 4139 - 4145. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. LANG, A. HARTNER, R. B. STERZEL, and H. O. SCHÖCKLMANN Requirement of Cyclin D1 in Mesangial Cell Mitogenesis J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1398 - 1408. [Abstract] [Full Text]
|
|
|
|
|
|
C. Albanese, M. D'Amico, A. T. Reutens, M. Fu, G. Watanabe, R. J. Lee, R. N. Kitsis, B. Henglein, M. Avantaggiati, K. Somasundaram, et al. Activation of the cyclin D1 Gene by the E1A-associated Protein p300 through AP-1 Inhibits Cellular Apoptosis J. Biol. Chem., November 26, 1999; 274(48): 34186 - 34195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Choi, Y. W. Eom, Y. Kang, M. J. Ha, H. Rhee, J.-W. Yoon, and S.-J. Kim Cdc2 and Cdk2 Kinase Activated by Transforming Growth Factor-beta 1 Trigger Apoptosis through the Phosphorylation of Retinoblastoma Protein in FaO Hepatoma Cells J. Biol. Chem., November 5, 1999; 274(45): 31775 - 31783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pavlova, R. O. Stuart, M. Pohl, and S. K. Nigam Evolution of gene expression patterns in a model of branching morphogenesis Am J Physiol Renal Physiol, October 1, 1999; 277(4): F650 - F663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Albrecht and L. K. Hansen Cyclin D1 Promotes Mitogen-independent Cell Cycle Progression in Hepatocytes Cell Growth Differ., June 1, 1999; 10(6): 397 - 404. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Driscoll, S. Buckley, L. Barsky, K. Weinberg, K. D. Anderson, and D. Warburton Abrogation of cyclin D1 expression predisposes lung cancer cells to serum deprivation-induced apoptosis Am J Physiol Lung Cell Mol Physiol, April 1, 1999; 276(4): L679 - L687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Coco Martin, A. Balkenende, T. Verschoor, F. Lallemand, and R. Michalides Cyclin D1 Overexpression Enhances Radiation-induced Apoptosis and Radiosensitivity in a Breast Tumor Cell Line Cancer Res., March 1, 1999; 59(5): 1134 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Quintanilla-Martinez, C. Thieblemont, F. Fend, S. Kumar, M. Pinyol, E. Campo, E. S. Jaffe, and M. Raffeld Mantle Cell Lymphomas Lack Expression of p27kip1, a Cyclin-Dependent Kinase Inhibitor Am. J. Pathol., July 1, 1998; 153(1): 175 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Meyyappan, H. Wong, C. Hull, and K. T. Riabowol Increased Expression of Cyclin D2 during Multiple States of Growth Arrest in Primary and Established Cells Mol. Cell. Biol., June 1, 1998; 18(6): 3163 - 3172. [Abstract] [Full Text]
|
|
|
|
|
|
G. Watanabe, C. Albanese, R. J. Lee, A. Reutens, G. Vairo, B. Henglein, and R. G. Pestell Inhibition of Cyclin D1 Kinase Activity Is Associated with E2F-Mediated Inhibition of Cyclin D1 Promoter Activity through E2F and Sp1 Mol. Cell. Biol., June 1, 1998; 18(6): 3212 - 3222. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Fredersdorf, J. Burns, A. M. Milne, G. Packham, L. Fallis, C. E. Gillett, J. A. Royds, D. Peston, P. A. Hall, A. M. Hanby, et al. High level expression of p27kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27kip1 and degree of malignancy in human breast and colorectal cancers PNAS, June 10, 1997; 94(12): 6380 - 6385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Lahti, H. Li, and V. J. Kidd Elimination of Cyclin D1 in Vertebrate Cells Leads to an Altered Cell Cycle Phenotype, Which Is Rescued by Overexpression of Murine Cyclins D1, D2, or D3 but Not by a Mutant Cyclin D1 J. Biol. Chem., April 18, 1997; 272(16): 10859 - 10869. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
